Toxicology Letters 2013-07-31

Dose-response involvement of constitutive androstane receptor in mouse liver hypertrophy induced by triazole fungicides.

Kei Tamura, Kaoru Inoue, Miwa Takahashi, Saori Matsuo, Kaoru Irie, Yukio Kodama, Shogo Ozawa, Akiyoshi Nishikawa, Midori Yoshida

Index: Toxicol. Lett. 221(1) , 47-56, (2013)

Full Text: HTML

Abstract

To clarify the dose-response relationship between constitutive androstane receptor (CAR) activity and induction of cytochrome P450 2B (CYP2B) expression and hypertrophy by triazole fungicides in mouse liver, three dose levels of cyproconazole (Cypro), tebuconazole (Teb), fluconazole (Flu), and phenobarbital (PB), a typical CYP2B inducer, were administrated in diet to male wild-type (WT) and CAR-knockout (CARKO) mice for one week. In WT mice, all compounds dose-dependently induced liver weight increases and hepatocellular hypertrophy accompanied by CYP2B expression. In CARKO mice, these effects were not induced by PB, while Cypro or Flu induced these effects only at the highest dose. Dose-dependent liver hypertrophy was detected in CARKO mice treated with Teb, but at the lowest dose the intensity was weakened compared to WT mice. The present results indicate that Cypro and Flu mainly induced CAR-mediated liver hypertrophy, while Teb slightly involved CAR. The involvement of CAR in triazole-induced liver hypertrophy was dose-responsive. In addition, all three triazoles have non-CAR-mediated liver hypertrophy pathways, indicating that the hypertrophy induced by these triazoles differs from that of PB.Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Related Compounds

Structure Name/CAS No. Articles
phenobarbital Structure phenobarbital
CAS:50-06-6
tebuconazole Structure tebuconazole
CAS:107534-96-3
Cyproconazole Structure Cyproconazole
CAS:94361-06-5
Fluconazole Structure Fluconazole
CAS:86386-73-4